A primary care doctor at the University of Vermont Health Network will soon start treating depression with a mind-altering drug that’s shown promise in helping people who don’t respond to traditional medicine. The medication — known as esketamine and sold by Johnson & Johnson under the brand name Spravato — is chemically similar to ketamine, […]
